In the colorectal dataset, GSTM1 demonstrated a high negative correlation in all stages prior to stage T4a, whereas in stage T4b this was completely lost, suggesting that low levels of GSTM1 are associated with the onset and progression of colorectal cancer. This evidence concerns the gene GSTM1 and colorectal cancer.